School of Medicine

Weikai Li, along with Michael J. Greenberg, both at the School of Medicine, and Michael L. Gross, in Arts & Sciences, received a three-year $750,000 grant from American Heart Association for their research titled “Interdisciplinary structural studies of iron homeostasis in cardiovascular health.”

Kenneth R. Boschert, DVM, associate director of the Division of Comparative Medicine at Washington University School of Medicine, has received the Charles A. Griffin Award from the American Association for Laboratory Animal Science. The award recognizes those in veterinary medicine who have demonstrated ethical scientific or technological advancements in humane experimentation or improved animal care practices.

Researchers at the School of Medicine and Whiterabbit.ai have developed a software that assesses breast density and can help identify women who could benefit from additional screening.

In a small study, researchers at Washington University School of Medicine found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients.

James M. DuBois, the Steven J. Bander Professor of Medical Ethics and Professionalism, and Kenneth M. Ludmerer, MD, the Mabel Dorn Reeder Distinguished Professor of the History of Medicine at Washington University School of Medicine in St. Louis, have been named Hastings Center Fellows. The Hastings Center addresses social and ethical issues in health care, science and technology.

Researchers at Washington University School of Medicine have used light to decode brain signals and identify what image a person sees. It could be a step toward helping people who are unable to express themselves because of brain injury or disease communicate.

Researchers at Washington University School of Medicine have engineered cartilage cells to release an anti-inflammatory drug in response to stresses such cells undergo when they are compressed during weight bearing and movement.

Researchers at Washington University School of Medicine have found that immune cells stationed in such sinuses monitor the brain and initiate an immune response if they detect a problem.

A new study from Washington University School of Medicine suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.

Michael S. Kinch, associate vice chancellor and director of the Centers for Research Innovation in Biotechnology and Drug Discovery, and professor of biochemistry and molecular biophysics at the School of Medicine,, received a one-year $280,385 grant from Arnold Ventures for his research titled “CDEK: Clinical Data Experience Knowledge-base.”